|
Colorectal Neoplasms
|
0.700 |
ModifyingMutation
|
group |
RGD |
Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats.
|
17893236 |
2008 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells.
|
15888491 |
2005 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis.
|
15102686 |
2004 |
|
Colorectal Neoplasms
|
0.700 |
GeneticVariation
|
group |
LHGDN |
The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis.
|
11920497 |
2002 |
|
Colorectal Neoplasms
|
0.700 |
PosttranslationalModification
|
group |
LHGDN |
DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications.
|
18538736 |
2008 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study.
|
16356174 |
2005 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
Beta-catenin expression in relation to genetic instability and prognosis in colorectal cancer.
|
17203186 |
2007 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Nuclear beta-catenin expression is closely related to ulcerative growth of colorectal carcinoma.
|
11953860 |
2002 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Relation of E-cadherin and beta-catenin expression to pit pattern in colorectal cancer.
|
15289833 |
2004 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Positive KL-6 mucin expression combined with decreased membranous beta-catenin expression indicates worse prognosis in colorectal carcinoma.
|
18949395 |
2008 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
|
12209953 |
2002 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
Prognostic significance of beta-catenin in colorectal cancer with liver metastasis.
|
17168211 |
2006 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinoma.
|
18609711 |
2008 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer.
|
14977843 |
2004 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers.
|
15254684 |
2004 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription.
|
18591935 |
2008 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression.
|
16507986 |
2006 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells.
|
15331612 |
2004 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Pin1 overexpression in colorectal cancer and its correlation with aberrant beta-catenin expression.
|
16124054 |
2005 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Expression level of Wnt signaling components possibly influences the biological behavior of colorectal cancer in different age groups.
|
15126105 |
2004 |
|
Colorectal Neoplasms
|
0.700 |
AlteredExpression
|
group |
LHGDN |
Cell-cycle and apoptosis regulators (p16INK4A, p21CIP1, beta-catenin, survivin, and hTERT) and morphometry-defined MPECs predict metachronous cancer development in colorectal adenoma patients.
|
17641414 |
2007 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
LHGDN |
A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth.
|
16953230 |
2007 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
CTD_human |
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
|
21291235 |
2011 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
CTD_human |
Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression.
|
25280562 |
2014 |
|
Colorectal Neoplasms
|
0.700 |
Biomarker
|
group |
CTD_human |
More frequent beta-catenin gene mutations in adenomas than in aberrant crypt foci or adenocarcinomas in the large intestines of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-treated rats.
|
10965019 |
2000 |